Mip-C is an acronym that is worrying those involved in research on the Covid virus, a new condition that can develop in individuals infected by the virus that is no longer pandemic, as a recent study has shown. “This is Mda5 autoimmunity and interstitial pneumonia contemporary with Covid, but it is a distinctive form of dermatomyositis – an autoimmune disease – in which the body develops antibodies towards structures of the body itself, from muscles to skin. Today this international study tells us that Sars-CoV-2 infection is the trigger. Dermatomyositis is a serious disease, even lethal in some cases. This and other studies are shining a light on how Sars-CoV-2 can trigger autoimmune diseases, Mip-C will not be the only one“. The report for Adnkronos Salute is infectious disease specialist Massimo Andreoni, scientific director of Simit, the Italian Society of Infectious Diseases, and full professor at the Tor Vergata University of Rome.
The line of studies that is examining this condition, Mip-C, “is very interesting because after 4 years of work on Sars-CoV-2 New links are being discovered with several autoimmune diseases. The cause of dermatomyositis was hypothesized to be a virus – continues Andreoni – and today we know that Covid most likely plays a role”. A pathogen that continues to create problems, then? “Many discoveries come precisely because we are studying as a scientific community in this respiratory virus in great depth, therefore – he concludes – in the near future we will find other diseases linked to this infection”.
#Covid #fuse #autoimmune #diseases #Andreoni #MipC
